课题基金 / 基金详情

Cancer Care Quality Training Program

Cancer Care Quality Training Program
癌症护理质量培训计划
批准号:
10459369
负责人:
ETHAN M. BASCH
金额:
$30.7万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2023-07-31

项目摘要

项目成果

ETHAN M. BASCH的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 评估和改进癌症护理服务在全国范围内日益受到关注,迫切需要 支持政策制定者、医院系统、付款人、临床医生和患者决策的研究。然而,在那里 受过适当培训的调查人员数量有限,可以在这一领域进行严格的研究。至 为了满足这一需求,北卡罗来纳大学莱恩伯格综合癌症中心寻求更新其R25T癌症护理 质量培训计划(CCQTP)作为T32(11-16年级)。未来五年,CCQTP提出 每年支持博士后和博士后研究员,并为他们在多学科和协作方面的职业生涯提供培训 研究的重点是癌症护理服务的质量。由三位联席董事Ethan Basch博士、Stephanie领导 惠勒和布莱斯·里夫,以及由四名外部顾问支持的跨学科指导委员会, CCQTP培训了各种研究员,包括行为科学家、流行病学家和医生 相关学科。CCQTP对我们的实习生有四个目标:1)掌握一个内容领域和 展示相关研究方法的能力;2)通过学习 互补内容领域的基本原则;3)在以下指导下获得指导研究专业知识 多学科教授;以及4)培养成功的研究生涯所需的专业技能, 包括展示研究成果,撰写出版文章,以及获得研究资金。灵活的 培训是为每个研究员的需要量身定做的,包括三个基本要素:a)专门的核心 课程包括课程作业、丰富课程(研讨会、专题研讨会、期刊俱乐部等)。 负责任的研究行为和培训;b)由以下团队指导的实践研究经验 有经验的教员;c)专业发展,包括撰写补助金的经验。 培训一般为期两年,工资和研究/发展津贴的设计为 与北卡罗来纳大学的其他培训计划保持一致。北卡罗来纳大学优秀的研究环境包括: 资助和国家认可的癌症健康政策和管理方案;流行病学; 药物经济学和临床医学。CCQTP与全国各地的 公认的北卡罗来纳大学吉林斯全球公共卫生学院、医学院和伊谢尔曼学院 药房,并利用每个中心的核心设施。我们的20个P受体和14个附属机构已被选中 因为他们在奖学金、资金和指导方面的良好记录。所有已完成课程的学员 目前担任与CCQTP的内容和目标一致的研究相关职位。尽管 CCQTP是一个相对年轻的项目,它的学员已经出版了346份与癌症有关的出版物,有138份 与计划相关的出版物,其中大多数包括CCQTP教官合著者。基于我们的成功, 在过去的十年和庞大的候选人库中,我们寻求将博士后研究员从2名和2名扩大到3名和3名, 北卡罗来纳大学的丰富环境和完善的导师模式可以轻松适应这一点。
英文摘要
ABSTRACT Evaluation and improvement of cancer care delivery is of growing interest nationally, with a pressing need for research to support decisions by policy makers, hospital systems, payers, clinicians, and patients. Yet, there are a limited number of investigators with appropriate training to conduct rigorous research in this field. To address this need, the UNC Lineberger Comprehensive Cancer Center seeks to renew its R25T Cancer Care Quality Training Program (CCQTP) as a T32 (Years 11-16). During the next five years, the CCQTP proposes to support pre- and postdoctoral fellows yearly and train them for careers in multidisciplinary and collaborative research focused on quality of cancer care delivery. Led by three co-directors, Drs. Ethan Basch, Stephanie Wheeler, and Bryce Reeve, and an interdisciplinary Steering Committee supported by four external advisors, the CCQTP trains a variety of fellows, including behavioral scientists, epidemiologists, and physicians in relevant disciplines. The CCQTP has four objectives for our trainees: 1) to master a content area and demonstrate competence in pertinent research methods; 2) to develop collaborative capability by learning the basic principles of complementary content areas; 3) to gain mentored research expertise with the guidance of multidisciplinary preceptors; and 4) to develop professional skills required for a successful research career, including presenting research findings, writing for publication, and securing research funding. The flexible training is tailored to suit each fellow's needs and includes three basic elements: a) a specialized core curriculum that includes coursework, enrichment programs (seminars, special workshops, journal clubs, etc.) and training in the responsible conduct of research; b) hands-on research experience directed by teams of experienced faculty preceptors; and c) professional development, including experience in grant writing. Training generally lasts for two years, with salaries and research/development allowances designed to be consistent with other training programs at UNC. The outstanding research environment at UNC includes well- funded and nationally recognized programs in Cancer Health Policy and Management; Epidemiology; Pharmacoeconomics; and Clinical Medicine. The CCQTP enjoys close collaborations with the nationally recognized UNC Gillings School of Global Public Health, School of Medicine, and Eshelman School of Pharmacy, and makes use of core facilities in each. Our 20 Preceptors and 14 Affiliates have been selected for their strong records of scholarship, funding, and mentorship. All trainees who have completed the program are currently in research-related positions aligned with the content and goals of the CCQTP. Although the CCQTP is a relatively young program, its trainees have produced 346 cancer-related publications, with 138 program-related publications, most which include CCQTP preceptor co-authors. Based on our success the past decade and large candidate pool, we seek to expand from 2 pre- and 2 postdoctoral fellows to 3 and 3, which the rich environment at UNC and well developed mentorship model can comfortably accommodate.
期刊论文(119)
专著(0)
科研奖励(0)
会议论文
Risk-Reducing Salpingectomy Versus Standard Tubal Sterilization: Lessons From Offering Women Options for Interval Sterilization.
降低风险的输卵管切除术与标准输卵管绝育:为女性提供间隔绝育选择的经验教训。
DOI: 10.14423/smj.0000000000000779
发表时间: 2018
期刊: Southern medical journal
影响因子: 1.1
作者: [Zerden,MatthewL, Castellano,Tara, Doll,KemiM, Stuart,GretchenS, Munoz,MCris, Boggess,KimA]
通讯作者: Boggess,KimA
False positive mammograms in Europe: do they affect reattendance?
欧洲乳房X光检查假阳性:它们会影响复诊吗?
DOI: 10.1007/s10549-010-1245-9
发表时间: 2011
期刊: Breast cancer research and treatment
影响因子: 3.8
作者: [Salz,Talya, DeFrank,JessicaT, Brewer,NoelT]
通讯作者: Brewer,NoelT
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.
贝伐珠单抗治疗晚期结直肠癌的早期传播:一项前瞻性队列研究。
DOI: 10.1186/1471-2407-11-354
发表时间: 2011
期刊: BMC cancer
影响因子: 3.8
作者: [Zafar,SYousuf, Malin,JenniferL, Grambow,StevenC, Abbott,DavidH, Schrag,Deborah, Kolimaga,JaneT, Zullig,LeahL, Weeks,JaneC, Fouad,MonaN, Ayanian,JohnZ, Wallace,Robert, Kahn,KatherineL, Ganz,PatriciaA, Catalano,Paul, West,DeeW, Pr]
通讯作者: Pr
DOI: 10.1002/cncr.28004
发表时间: 2013-06-15
期刊: CANCER
影响因子: 6.2
作者: [Ellis, Shellie D., Blackard, Bonny, Carpenter, William R., Mishel, Merle, Chen, Ronald C., Godley, Paul A., Mohler, James L., Bensen, Jeannette T.]
通讯作者: Bensen, Jeannette T.
共 64 条
    Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
    Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
    Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
    Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
    海外基金